Search Results - Xinxing Du

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Modelling the tumor microenvironment in vitro in prostate cancer: current and future perspectives by Kedi Yuan, Xinxing Du, Liang Dong, Jiahua Pan, Wei Xue

    Published in View (2024-10-01)
    Get full text
    Article


  2. 2

    Mendelian randomization evidence based on European ancestry for the causal effects of leukocyte telomere length on prostate cancer by Xinrui Wu, Cong Hu, Tianyang Wu, Xinxing Du, Zehong Peng, Wei Xue, Yonghui Chen, Liang Dong

    Published in Human Genomics (2024-06-01)
    Get full text
    Article


  3. 3

    Targeting SOX4/PCK2 signaling suppresses neuroendocrine trans-differentiation of castration-resistant prostate cancer by Nan Jing, Zhenkeke Tao, Xinxing Du, Zhenzhen Wen, Wei-Qiang Gao, Baijun Dong, Yu-Xiang Fang

    Published in Biology Direct (2024-07-01)
    Get full text
    Article


  4. 4

    Taurine Inhibits Ferroptosis Mediated by the Crosstalk between Tumor Cells and Tumor‐Associated Macrophages in Prostate Cancer by Huixiang Xiao, Xinxing Du, Zhenkeke Tao, Nan Jing, Shijia Bao, Wei‐Qiang Gao, Baijun Dong, Yu‐Xiang Fang

    Published in Advanced Science (2024-01-01)
    Get full text
    Article


  5. 5

    Correction: PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5Amediated chromatin accessibility by Nan Jing, Xinxing Du, Yu Liang, ZhenKeke Tao, Shijia Bao, Huixiang Xiao, Baijun Dong, Wei-Qiang Gao, Yu-Xiang Fang

    Get full text
    Article


  6. 6

    PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5A-mediated chromatin accessibility by Nan Jing, Xinxing Du, Yu Liang, ZhenKeke Tao, Shijia Bao, Huixiang Xiao, Baijun Dong, Wei-Qiang Gao, Yu-Xiang Fang

    Get full text
    Article


  7. 7

    The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study by Xiaochen Fei, Liancheng Fan, Wei Chen, Wei Chen, Yiming Gong, Xinxing Du, Yanqing Wang, Yinjie Zhu, Jiahua Pan, Fangqin Wang, Wanbing Zhao, Tongtong Liu, Yining Yang, Baijun Dong, Wei Xue

    Published in Clinical and Translational Medicine (2021-10-01)
    Get full text
    Article


  8. 8

    Engineering the MoS2/MXene Heterostructure for Precise and Noninvasive Diagnosis of Prostate Cancer with Clinical Specimens by Shaowei Xie, Xiaochen Fei, Jiayi Wang, Yi‐Cheng Zhu, Jiazhou Liu, Xinxing Du, Xuesong Liu, Liang Dong, Yinjie Zhu, Jiahua Pan, Baijun Dong, Jianjun Sha, Yu Luo, Wenshe Sun, Wei Xue

    Published in Advanced Science (2023-05-01)
    Get full text
    Article


  9. 9

    RNA profiling of circulating tumor cells systemically captured from diagnostic leukapheresis products in prostate cancer patients by Liang Dong, Xinxing Du, Changxue Lu, Zhongyuan Zhang, Chung-Ying Huang, Lei Yang, Sarah Warren, Morgan D. Kuczler, Diane K. Reyes, Jun Luo, Sarah R. Amend, Wei Xue, Kenneth J. Pienta

    Published in Materials Today Bio (2022-12-01)
    Get full text
    Article


  10. 10

    Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancer by Xinxing Du, Xiaochen Fei, Jialin Wang, Yanhao Dong, Liancheng Fan, Bin Yang, Wei Chen, Yiming Gong, Binbin Xia, Hanjing Zhu, Fan Wu, Yanqing Wang, Liang Dong, Yinjie Zhu, Jiahua Pan, Xudong Yao, Baijun Dong

    Published in Translational Oncology (2023-08-01)
    Get full text
    Article


  11. 11

    IL‐1β Is an Androgen‐Responsive Target in Macrophages for Immunotherapy of Prostate Cancer by Deng Wang, Chaping Cheng, Xinyu Chen, Jinming Wang, Kaiyuan Liu, Na Jing, Penghui Xu, Xialian Xi, Yujiao Sun, Zhongzhong Ji, Huifang Zhao, Yuman He, Kai Zhang, Xinxing Du, Baijun Dong, Yuxiang Fang, Pengcheng Zhang, Xueming Qian, Wei Xue, Wei‐Qiang Gao, Helen He Zhu

    Published in Advanced Science (2023-06-01)
    Get full text
    Article


Search Tools: